Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
36 active Medicare policies list M45.0, and 10 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
10 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M45.0 |
|---|---|---|
| Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation | Aug 30, 2023 | Covered |
| Cryoablation | Dec 5, 2023 | Covered |
| Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications | Aug 31, 2023 | Covered |
| Intradiscal Procedures | Aug 30, 2023 | Covered |
| Pulmonary Rehabilitation | Mar 15, 2023 | Covered |
| Radiation Treatment for Selected Nononcologic Indications | Jul 27, 2023 |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J5 · Effective Nov 27, 2025
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2024
National · Effective Oct 16, 2025
| Thermography | Mar 15, 2023 | Covered |
|---|
| Zoledronic Acid | Feb 1, 2024 | Covered |
|---|
| Policy | Effective | Status of M45.0 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |
| Policy | Effective | Status of M45.0 |
|---|---|---|
| Cosentyx (Secukinumab) | Jun 1, 2026 | Covered |